Filtered By:
Education: University of Pennsylvania

This page shows you your search results in order of date. This is page number 2.

Order by Relevance | Date

Total 50 results found since Jan 2013.

Insurance company requirements place heavy administrative burden on physicians seeking to prescribe new cholesterol-lowering drugs
(University of Pennsylvania School of Medicine) A rare glimpse into the prior authorization requirements implemented by public and private insurance providers across the country has found substantial administrative burden for a new class of medications for patients with high cholesterol that places them at high risk for heart attack or stroke, according to new research.
Source: EurekAlert! - Medicine and Health - January 16, 2018 Category: International Medicine & Public Health Source Type: news

Winter babies are more at risk of a stroke in later life
Researchers from the University of Pennsylvania found mothers whose first trimesters were during summer are more likely to have children with irregular heartbeats as they were exposed to air pollution.
Source: the Mail online | Health - November 15, 2017 Category: Consumer Health News Source Type: news

How Genomic Research is Changing Heart Care
Genomic testing is most frequently associated with cancer testing, but this area of research is beginning to make an impact on cardiovascular care. A recent scientific statement by the American Heart Association shined a spotlight on how the expressed genome can potentially be used to diagnose diseases and predict who will develop diseases such as coronary artery disease (CAD), stroke, heart failure, and arrhythmias. According to the statement, scientists now have the ability to address disease at many levels that were inaccessible during the past century. This includes the genome, transcriptome, epigenome, proteome, metab...
Source: MDDI - October 27, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: IVD Cardiovascular Source Type: news

Falling off the health-care radar
Vani S. Kulkarni is a Lecturer in Sociology, University of Pennsylvania, U.S.; Raghav Gaiha is (Hon.) Professorial Research Fellow, Global Development Institute, University of Manchester, U.K.By Vani S. Kulkarni and Raghav GaihaPHILADELPHIA and NEW DELHI, Sep 28 2017 (IPS)Care for the elderly needs to be better targeted by the health system and social networks. The National Health Policy (NHP), 2017 is unable to see the wood for the trees. Life and death questions are dealt with perfunctorily or simply overlooked. For example, it overlooks the rapid rise in the share of the old (60 years or more), and associated morbiditie...
Source: IPS Inter Press Service - Health - September 28, 2017 Category: International Medicine & Public Health Authors: S Kulkami Tags: Aid Asia-Pacific Headlines Health Human Rights TerraViva United Nations Source Type: news

Care for the elderly needs to be better targeted by the health system and social networks
Vani S. Kulkarni is a Lecturer in Sociology, University of Pennsylvania, U.S.; Raghav Gaiha is (Hon.) Professorial Research Fellow, Global Development Institute, University of Manchester, U.K.By Vani S. Kulkarni and Raghav GaihaPHILADELPHIA and NEW DELHI, Sep 28 2017 (IPS)The National Health Policy (NHP), 2017 is unable to see the wood for the trees. Life and death questions are dealt with perfunctorily or simply overlooked. For example, it overlooks the rapid rise in the share of the old (60 years or more), and associated morbidities, especially sharply rising non-communicable diseases (NCDs) and disabilities. With rising...
Source: IPS Inter Press Service - Health - September 28, 2017 Category: International Medicine & Public Health Authors: S Kulkami Tags: Aid Asia-Pacific Headlines Health Human Rights Source Type: news

Medtronic readies pivotal trial in renal denervation
Medtronic (NYSE:MDT) said today that it’s ready for a run at FDA approval for renal denervation in treating high blood pressure, more than three years after the failure of a high-profile clinical trial. Back in January 2014, Fridley, Minn.-based Medtronic shocked medtech when it announced that the highly anticipated Symplicity HTN-3 trial, examining ablation of the around the renal arteries in treating hypertension, failed to meet its efficacy endpoint. The company suspended enrollment in its other Symplicity trials around the world and later took a $200 million write-down on its renal denervation assets. News of th...
Source: Mass Device - August 28, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Clinical Trials Wall Street Beat Medtronic Renal Source Type: news

ESOC 2017 Roundup: Gore touts lowered ischemic stroke, new brain infarcts in PFO Occluder test
W.L. Gore & Associates yesterday released results from the Reduce study of its Cardioform Septal Occluder devices used to close patent foramen ovale, touting a reduction in recurrent ischemic strokes and new brain infarcts. The Gore Cardioform Septal Occluder is designed to be inserted via catheter and is currently cleared by the FDA for closure of atrial septal defects. “It is of the utmost importance to us to be transparent and share clinical data as quickly as possible. We completed our two-year primary endpoint follow-up with patients in March and have worked diligently to release these important data to the ...
Source: Mass Device - May 17, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Catheters Clinical Trials Stryker W.L. Gore & Associates Source Type: news

Donald Trump Thinks Exercise Is Bad For You
Nothing is safe from alternative facts ― even exercise. According to Donald Trump, physical fitness is useless. As the Washington Post’s Michael Kranish and Marc Fisher wrote in their new book, Trump Revealed, Trump believes a sweat session actually does more harm than good: After college, after Trump mostly gave up his personal athletic interests, he came to view time spent playing sports as time wasted. Trump believed the human body was like a battery, with a finite amount of energy, which exercise only depleted. So he didn’t work out. The book also states that when Trump learned that one of his...
Source: Healthy Living - The Huffington Post - May 1, 2017 Category: Consumer Health News Source Type: news

Validation of olfactory deficit as a biomarker of Alzheimer disease
Conclusions: Olfactory identification deficit is a useful screening tool for AD-related amnestic disorder, with sensitivity and specificity comparable to other established biomarkers, with benefits such as ease of administration and low cost. Olfactory identification deficit can be utilized to stratify risk of conversion from aMCI to AD and enrich clinical trials of disease-modifying therapy. Classification of evidence: This study provides Class III evidence that smell identification (10-item UPSIT subset) accurately identifies patients with amnestic disorders.
Source: Neurology Clinical Practice - February 12, 2017 Category: Neurology Authors: Woodward, M. R., Amrutkar, C. V., Shah, H. C., Benedict, R. H. B., Rajakrishnan, S., Doody, R. S., Yan, L., Szigeti, K., On behalf of the Texas Alzheimer Research and Care Consortium Tags: Alzheimer's disease, Class III, MCI (mild cognitive impairment) Research Source Type: research

Fat Shaming Can Literally Break Your Heart
This reporting is brought to you by HuffPost’s health and science platform, The Scope. Like us on Facebook and Twitter and tell us your story: scopestories@huffingtonpost.com.   Sarah DiGiulio is The Huffington Post’s sleep reporter. You can contact her at sarah.digiulio@huffingtonpost.com.  -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.
Source: Science - The Huffington Post - February 4, 2017 Category: Science Source Type: news

InVivo Therapeutics Q2 meets the street, shares stay steady
InVivo Therapeutics (NSDQ:NVIV) shares stayed steady after the company released 2nd quarter earnings that met the street on losses per share. The Cambridge, Mass.-based company reported losses of $5.2 million, or 16¢ per share, for the 3 months ended June 30, 2016. That amounts to a 50% reduction in losses for InVivo Therapeutics compared with same period in 2015. After adjusting to exclude 1-time items, losses per share were 18¢, a good tick below what analysts on Wall Street were looking for with expectations set fro losses of 22¢ per share. “The 2nd quarter was one marked by continued advancements and outreach...
Source: Mass Device - August 5, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Neurological Spinal InVivo Therapeutics Corp. Source Type: news

Blood thinners on 'as needed' basis is safe and effective for lowering stroke risk as compared to long-term use
(University of Pennsylvania School of Medicine) A new study shows the use of novel anticoagulants for AF prescribed on an 'as-needed basis' guided by diligent pulse monitoring, can be a safe and effective alternative to lowering overall risk of stroke. Researchers from the Perelman School of Medicine at the University of Pennsylvania presented their findings today at the Heart Rhythm Society's 37th Annual Scientific Session in San Francisco.
Source: EurekAlert! - Medicine and Health - May 6, 2016 Category: Global & Universal Source Type: news

$10 million gift to UCLA from Wendy and Leonard Goldberg is largest ever to support migraine research
UCLA Health Sciences has received a $10 million gift, most of which will support multidisciplinary research on migraine, a debilitating neurological disorder that affects 36 million people in the U.S. The gift was made by philanthropists Wendy and Leonard Goldberg. Wendy Goldberg is an editor and author; her husband, Leonard, is an award-winning film and television producer and executive. More than 90 percent of sufferers are unable to work during their migraine attacks, costing employers $13 billion a year in lost work days; and every 10 seconds, someone in the U.S. goes to an emergency room with a migraine-related compla...
Source: UCLA Newsroom: Health Sciences - December 8, 2015 Category: Universities & Medical Training Source Type: news

The 8 Most Important Things We've Learned About Happiness In The Past 10 Years
We're living in a golden age of happiness -- the scientific study of happiness, at least. The field of positive psychology has exploded in growth since its inception in 1998, dramatically increasing our understanding of human flourishing. We now know more than ever about what makes us happy, how we can spread happiness socially and geographically, and how happiness affects our physical and mental health. But it's just the beginning. In the next decade, we're likely to see not only a greater understanding of positive emotions, but also the application of this research on a practical level to improve well-being on a globa...
Source: Science - The Huffington Post - May 23, 2015 Category: Science Source Type: news